Lewis McCurdy

1.8k total citations
38 papers, 1.0k citations indexed

About

Lewis McCurdy is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Lewis McCurdy has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 13 papers in Epidemiology and 9 papers in Virology. Recurrent topics in Lewis McCurdy's work include Antifungal resistance and susceptibility (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (5 papers). Lewis McCurdy is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), HIV/AIDS drug development and treatment (5 papers) and HIV Research and Treatment (5 papers). Lewis McCurdy collaborates with scholars based in United States, United Kingdom and France. Lewis McCurdy's co-authors include Barney S. Graham, Stephen Dummer, Aaron P. Milstone, Brenda Larkin, Rima Abdel-Massih, Javeed Siddiqui, J. D. Young, John D. Scott, Brian R. Wood and Teresa R. Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Lewis McCurdy

36 papers receiving 998 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis McCurdy United States 16 465 456 324 166 102 38 1.0k
Susan Bersoff‐Matcha United States 13 305 0.7× 523 1.1× 158 0.5× 156 0.9× 61 0.6× 21 1.1k
Maximilian Muenchhoff Germany 19 232 0.5× 587 1.3× 236 0.7× 128 0.8× 200 2.0× 47 1.1k
Giuliano Rizzardini Italy 15 341 0.7× 800 1.8× 539 1.7× 130 0.8× 62 0.6× 39 1.3k
Mamta K. Jain United States 24 1.0k 2.2× 586 1.3× 229 0.7× 81 0.5× 76 0.7× 113 1.8k
Soyeon Kim United States 15 645 1.4× 966 2.1× 221 0.7× 144 0.9× 75 0.7× 40 1.2k
Stefania Bellino Italy 18 359 0.8× 477 1.0× 169 0.5× 128 0.8× 129 1.3× 45 1.1k
Barry Peters United Kingdom 21 292 0.6× 596 1.3× 454 1.4× 132 0.8× 180 1.8× 50 1.3k
Tiziana Quirino Italy 22 331 0.7× 841 1.8× 493 1.5× 188 1.1× 54 0.5× 60 1.5k
F. Raffi France 21 734 1.6× 721 1.6× 220 0.7× 89 0.5× 69 0.7× 71 1.5k
Reto Nüesch Switzerland 23 480 1.0× 660 1.4× 463 1.4× 77 0.5× 173 1.7× 51 1.7k

Countries citing papers authored by Lewis McCurdy

Since Specialization
Citations

This map shows the geographic impact of Lewis McCurdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis McCurdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis McCurdy more than expected).

Fields of papers citing papers by Lewis McCurdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis McCurdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis McCurdy. The network helps show where Lewis McCurdy may publish in the future.

Co-authorship network of co-authors of Lewis McCurdy

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis McCurdy. A scholar is included among the top collaborators of Lewis McCurdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis McCurdy. Lewis McCurdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pastey, Manoj K., Lewis McCurdy, & Barney S. Graham. (2025). Decoding respiratory syncytial virus morphology: distinct structural and molecular signatures of spherical and filamentous particles. Frontiers in Cellular and Infection Microbiology. 15. 1597279–1597279.
2.
Mounzer, Karam, Laurence Brunet, Jennifer S Fusco, et al.. (2023). Immune response to ART initiation in advanced HIV infection. HIV Medicine. 24(6). 716–726. 8 indexed citations
3.
Sension, Michael, Laurence Brunet, Jennifer S Fusco, et al.. (2023). Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort. Infectious Diseases and Therapy. 12(12). 2807–2817. 30 indexed citations
4.
5.
Mounzer, Karam, Laurence Brunet, Jennifer S Fusco, et al.. (2022). Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens. Open Forum Infectious Diseases. 9(3). ofac018–ofac018. 23 indexed citations
6.
Passaretti, Catherine, et al.. (2022). Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure. Vaccine. 40(9). 1213–1214. 5 indexed citations
7.
8.
Herrington, David M., John W. Sanders, Thomas F. Wierzba, et al.. (2021). Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership. BMC Infectious Diseases. 21(1). 889–889. 22 indexed citations
9.
Kowalkowski, Marc, Andrew McWilliams, Hazel Tapp, et al.. (2021). Protocol for a two-arm pragmatic stepped-wedge hybrid effectiveness-implementation trial evaluating Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship (ENCOMPASS). BMC Health Services Research. 21(1). 544–544. 4 indexed citations
10.
Wood, Brian R., J. D. Young, Rima Abdel-Massih, et al.. (2020). Advancing Digital Health Equity: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clinical Infectious Diseases. 72(6). 913–919. 58 indexed citations
11.
Taylor, Stephanie Parks, Shih‐Hsiung Chou, Andrew McWilliams, et al.. (2018). 1320: POST-SEPSIS CARE RECOMMENDATIONS ARE ASSOCIATED WITH IMPROVED PATIENT OUTCOMES BUT ADHERENCE IS LOW. Critical Care Medicine. 47(1). 636–636. 2 indexed citations
12.
Davidson, Lisa, et al.. (2017). Effect of a Multifaceted Stewardship Intervention on Antibiotic Prescribing and Outcomes for Acute Bacterial Skin and Skin Structure Infections. Open Forum Infectious Diseases. 4(suppl_1). S489–S489. 1 indexed citations
13.
Templin, Megan, et al.. (2016). Antifungal use in immunocompetent, critically ill patients with pneumonia does not improve clinical outcomes. Heart & Lung. 45(6). 538–543. 2 indexed citations
14.
Min, Sherene, Louis Sloan, Edwin DeJesus, et al.. (2011). Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults. AIDS. 25(14). 1737–1745. 171 indexed citations
15.
McCurdy, Lewis, John A. Rutigliano, Teresa R. Johnson, Man Chen, & Barney S. Graham. (2004). Modified Vaccinia Virus Ankara Immunization Protects against Lethal Challenge with Recombinant Vaccinia Virus Expressing Murine Interleukin-4. Journal of Virology. 78(22). 12471–12479. 22 indexed citations
16.
McCurdy, Lewis, et al.. (2004). Modified Vaccinia Ankara: Potential as an Alternative Smallpox Vaccine. Clinical Infectious Diseases. 38(12). 1749–1753. 76 indexed citations
17.
McCurdy, Lewis & Jason D. Morrow. (2003). Infections due to non-neoformans cryptococcal species. Comprehensive Therapy. 29(2-3). 95–101. 20 indexed citations
18.
McCurdy, Lewis, Aaron P. Milstone, & Stephen Dummer. (2003). Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. The Journal of Heart and Lung Transplantation. 22(7). 745–753. 78 indexed citations
19.
McCurdy, Lewis, W. Winn Chatham, & Warren D. Blackburn. (1995). Rheumatoid synovial fibroblast adhesion to human articular cartilage. Arthritis & Rheumatism. 38(11). 1694–1700. 14 indexed citations
20.
McCurdy, Lewis, et al.. (1973). A controlled study of single-dose administration of imipramine pamoate in endogenous depression.. PubMed. 15(10). 700–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Bersoff‐Matcha Breakdown of academic impact, for papers by Maximilian Muenchhoff Breakdown of academic impact, for papers by Giuliano Rizzardini Breakdown of academic impact, for papers by Mamta K. Jain Breakdown of academic impact, for papers by Soyeon Kim Breakdown of academic impact, for papers by Stefania Bellino Breakdown of academic impact, for papers by Barry Peters Breakdown of academic impact, for papers by Tiziana Quirino Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by Reto Nüesch
Rankless by CCL
2026